Application of Multiple Vertical Jump Tests in Return-to-Play Assessment for Anterior Cruciate Ligament Reconstruction Athletes
RTP-VJ
The Application of Vertical Jump Performance in Return-to-Play Assessment for Anterior Cruciate Ligament Reconstruction Athletes
1 other identifier
observational
36
1 country
1
Brief Summary
Anterior cruciate ligament (ACL) injury is a common sports-related injury, particularly in sports that require extensive jumping and cutting movements. Although anterior cruciate ligament reconstruction (ACLR) surgery can restore knee stability, many athletes still face the risk of re-injury after returning to competition.Current return-to-play assessment relies primarily on single-plane horizontal hop tests and symmetry indices (LSI ≥ 90%); however, an increasing body of research suggests that these tests may not comprehensively reflect functional deficits in the vertical plane, repeated hopping, or high-intensity sport-specific activities.This study hypothesizes that incorporating multiple vertical jump tests-including single-leg vertical jumps and 10-second repeated vertical jumps-combined with advanced force plate analytics (such as Reactive Strength Index \[RSI\] and Time to Stabilization \[TTS\])-can more sensitively reveal residual neuromuscular control deficits following surgery. This approach would provide evidence-based guidance for return-to-play decision-making, thereby improving athletes' long-term athletic performance and safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
December 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedDecember 22, 2025
July 1, 2025
1 month
December 9, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Limb asymmetry index,LSI
Limb Symmetry Index (LSI) calculated as (\|Uninvolved limb value - Involved limb value\| / (Uninvolved limb value + Involved limb value)) × 100% for each of the four jump tasks: Single-Legged Hop for Distance (SHD), Crossover Hop for Distance (CHD), Single-Legged Vertical Countermovement Jump (SLVJ), and 10-Second Repeated Single-Legged Vertical Jump (SLVJs). LSI values will be compared between ACLR athletes and healthy controls to determine whether vertical jump protocols reveal greater limb asymmetries than traditional horizontal hop tests. Primary analysis will examine whether LSI differences in vertical jump tasks are statistically significantly lower (indicating greater asymmetry) than horizontal hop tasks, revealing residual neuromuscular deficits not detected by conventional return-to-play assessment.
At baseline (single testing session; no longitudinal follow-up)
Secondary Outcomes (5)
Modified Reactive Strength Index
At baseline (single testing session; no longitudinal follow-up)
Time to Stabilization (seconds)
At baseline (single testing session; no longitudinal follow-up)
Single-Legged Hop for Distance (centimeter)
At baseline (single testing session; no longitudinal follow-up)
Crossover Hop for Distance (centimeter)
At baseline (single testing session; no longitudinal follow-up)
Jump Height(meter)
At baseline (single testing session; no longitudinal follow-up)
Study Arms (2)
Health: Control group
The group include athletes with no lower limbs injury.Participants must be aged 18-35 years and must be elite athletes who have competed in national-level competitions.
ACL reconstruction
Participants must be aged 18-35 years with unilateral ACL rupture confirmed by MRI, Lachman test grade ≥2, and reconstruction using hamstring or gracilis autograft with at least 6 months post-operative. Participants must have completed rehabilitation with clearance from an orthopedic surgeon or physical therapist, demonstrate no other lower extremity injuries, and have no contralateral lower limb injury within the past 3 months. Additionally, quadriceps strength symmetry index must be ≥90%, and participants must be elite athletes who have competed in national-level competitions.
Eligibility Criteria
The study population consists of two distinct groups: (1) ACLR athletes: elite athletes aged 18-35 years who have undergone unilateral anterior cruciate ligament reconstruction using hamstring or gracilis autograft with a minimum of 6 months post-operative. These participants will be recruited from orthopedic clinics, sports medicine centers, and rehabilitation facilities in the region. (2) Healthy controls: age, sex, and athletic-level matched individuals aged 18-35 years with no history of lower extremity injuries, recruited from local athletic facilities, university sports programs, and community sports organizations. Both groups must have elite athlete status, defined as prior participation in national-level sports competitions. The ACLR group represents athletes in the late rehabilitation phase preparing for return-to-play, while the healthy control group serves as a reference for normal biomechanical performance.
You may qualify if:
- Age 18-35 years
- Unilateral anterior cruciate ligament (ACL) rupture confirmed by magnetic resonance imaging (MRI)
- Positive Lachman test grade ≥2 pre-operatively
- Anterior cruciate ligament reconstruction (ACLR) using hamstring or gracilis autograft
- Post-operative time ≥6 months
- Completed rehabilitation program with clearance from orthopedic surgeon or physical therapist
- Quadriceps strength symmetry index ≥90%
- Elite athlete status (prior participation in national-level competitions)
You may not qualify if:
- Other lower extremity injuries or pathologies (including other knee ligament injuries)
- Contralateral lower limb injury within the past 3 months
- Quadriceps strength symmetry index \<90%
- Non-elite athlete status (no prior national-level competition participation)
- Incomplete rehabilitation or lack of medical clearance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University
Kaohsiung City, Taiwan
Study Officials
- STUDY CHAIR
GUO L Y Professor and Dean of college, Ph.D.
Department of Sports Science, Kaohsiung Medical University, Taiwan
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 9, 2025
First Posted
December 22, 2025
Study Start
December 29, 2025
Primary Completion
January 30, 2026
Study Completion
January 30, 2026
Last Updated
December 22, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- De-identified individual participate data (IPD) and supporting information will be available starting 2 years after the publication of the primary study results and will remain accessible for 5 years.
- Access Criteria
- The related supporting documents will only be made available to qualified researchers affiliated with academic institutions, medical organizations, or public health agencies. Applicants must submit a detailed research proposal and ethical approval documents, and access will be granted only upon approval.
De-identified individual participant data (IPD) that underlie the main published results, including demographic characteristics and biomechanical outcome measures (e.g., jump height, limb symmetry index, RSI, TTS, and impulse), will be shared with qualified researchers upon reasonable request, after approval of a data use agreement and in accordance with applicable ethical and regulatory requirements.